Share
Scheer Intelligence features thoughtful and provocative conversations with "American Originals" -- people who, through a lifetime of engagement with political issues, offer unique and often surprising perspectives on the day's most important issues.
…
continue reading
Manage episode 493714696 series 1313319
Content provided by Ideastream Public Media. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Ideastream Public Media or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
The Cleveland Clinic is in the third year of a first-of-its-kind brain study that was launched in 2022. The aim of the study is to identify biomarkers for neurological disorders earlier and either slow the progression or stop the progression all together.
It's estimated that 1 in 6 people worldwide live with a neurological disorder—a broad term that can include Alzheimer's, epilepsy, multiple sclerosis, Parkinson's, and stroke among others.
The study is expected to last for 20 years. Currently, more than 3,500 people from 46 states including Northeast Ohio are taking part in the study. But more participants are needed.
Later, we talk to historian and author Brandy Schillace, Ph.D., about her new book, “The Intermediaries: A Weimar Story.” The book traces the story of the founding of the Institute for Sexual Science, the world’s first center for homosexual and transgender rights.
We conclude the show with the latest episode of our podcast, “Shuffle.”
367 episodes
))
